USE OF SPHINGOSYLPHOSPHORYLCHOLINE ANTAGONIST FOR RESTORING THE EXPRESSION OF ANTIMICROBIAL PEPTIDES
摘要
<p>A sphingosylphosphorylcholine(SPC) antagonist is provided to prevent and treat diseases related to the expression decrease of anti-bacterial peptide such as atopic dermatitis, and screen the SPC antagonist by analyzing the expression recover of gene or protein of the anti-bacterial peptide. The sphingosylphosphorylcholine(SPC) antagonist manufactures the medicine for restoring the expression of anti-bacterial peptide back to the normal level in mammal requiring the expression restoration of anti-bacterial peptide. The screening method of the sphingosylphosphorylcholine(SPC) antagonist comprises the steps of: treating the object with sphingosylphosphorylcholine or its derivative to inhibit expression of anti-bacterial peptide; and treating the object with the SPC antagonist candidate material, and analyzing the expression restoration level of the anti-bacterial peptide in the object.</p>
申请公布号
KR20090016595(A)
申请公布日期
2009.02.16
申请号
KR20087030865
申请日期
2006.12.08
申请人
AMOREPACIFIC CORPORATION
发明人
KIM, HYOUNG JUNE;KIM, HYUK;SUNG, KI SA;KIM, DAE KWON;SUNG, DAE SEOK;PARK, JONG HEE;CHO, SUN A;KIM, KWANG MI;LEE, CHANG HOON;KIM, JUNG JU